Janssen\'s Erleada combo smashes endpoints in advanced hormonesensitive prostate cancer httpbit.ly2QG8LPHÂ pharma cancer ProstateCancerpic.twitter.comgerkP6WWp3

Janssen's Erleada combo smashes endpoints in advanced hormone-sensitive prostate cancer http://bit.ly/2QG8LPH  #pharma #cancer #ProstateCancerpic.twitter.com/gerkP6WWp3

08:01 EDT 3 Jun 2019 | Pharmafile

Janssen's Erleada combo smashes endpoints in advanced hormone-sensitive prostate cancer http://bit.ly/2QG8LPH  #pharma #cancer #ProstateCancer pic.twitter.com/gerkP6WWp3

More From BioPortfolio on "Janssen's Erleada combo smashes endpoints in advanced hormone-sensitive prostate cancer http://bit.ly/2QG8LPH  #pharma #cancer #ProstateCancerpic.twitter.com/gerkP6WWp3"